5,112
Views
7
CrossRef citations to date
0
Altmetric
Public Health

Prevalence and associated factors of overweight and obesity among persons with type 2 diabetes in Africa: a systematic review and meta-analysis

ORCID Icon, ORCID Icon & ORCID Icon
Pages 696-713 | Received 25 Nov 2022, Accepted 15 Feb 2023, Published online: 23 Feb 2023

References

  • World Health Organization. 2022. Obesity rising in Africa, WHO analysis finds. Available from: https://www.afro.who.int/news/obesity-rising-africa-who-analysis-finds#.
  • International Diabetes Federation. IDF diabetes atlas | tenth edition [Internet]. 10th ed. 2022. [cited 2022 Jun 27]. Available from https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf.
  • Chikowore T, Ekoru K, Vujkovi M, et al. Polygenic prediction of type 2 diabetes in Africa. Diabetes Care. 2022;45(3):717–723.
  • Toplak H, Leitner DR, Harreiter J, et al. “Diabesity” – [“diabesity”-obesity and type 2 diabetes (update 2019)]. Wien Klin Wochenschr. 2019;131(S1):71–76.
  • Kalra S. Diabesity. J Pak Med Assoc. 2013;63(4):532–534.
  • Chadt A, Scherneck S, Joost HG, et al. 2018. Molecular links between obesity and diabetes: “diabesity”. In: Feingold KR, editor. Endotext. South Dartmouth (MA): MDText.com, Inc.
  • Hlatky MA, Chung SC, Escobedo J, et al. The effect of obesity on quality of life in patients with diabetes and coronary artery disease. Am Heart J. 2010;159(2):292–300.
  • Zhang P, Brown MB, Bilik D, et al. Health utility scores for people with type 2 diabetes in U.S. managed care health plans: results from translating research into action for diabetes (TRIAD). Diabetes Care. 2012;35(11):2250–2256.
  • Yuyun MF, Sliwa K, Kengne AP, et al. Cardiovascular diseases in Sub-Saharan Africa compared to high-income countries: an epidemiological perspective. gh. 2020;15(1):15.
  • Grams J, Garvey WT. Weight loss and the prevention and treatment of type 2 diabetes using lifestyle therapy, pharmacotherapy, and bariatric surgery: mechanisms of action. Curr Obes Rep. 2015;4(2):287–302.
  • American Diabetes Association. Standards of medical care in diabetes-2022 abridged for primary care providers. Clin Diabetes. 2022;40(1):10–38.
  • World Health Organization. 2010. Available from: https://www.who.int/europe/news-room/fact-sheets/item/a-healthy-lifestyle–-who-recommendations.
  • Munn Z, Stern C, Aromataris E, et al. What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences. BMC Med Res Methodol. 2018;18(1):5.
  • Mann CJ. Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J. 2003;20(1):54–60.
  • Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statist Med. 2002;21(11):1539–1558.
  • Warton DI, Hui FK. The arcsine is asinine: the analysis of proportions in ecology. Ecology. 2011;92(1):3–10.
  • Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
  • Ali YA, Almobarak AO, Awadalla H, et al. Obesity among Sudanese adults with diabetes: a population-based survey. Ann Transl Med. 2017;5(12):252–252.
  • Abdissa D, Dukessa A, Babusha A. Prevalence and associated factors of overweight/obesity among type2 diabetic outpatients in southwest Ethiopia. Heliyon. 2021;7(2):e06339.
  • Bizuayehu T, Menjetta T, Mohammed M. Obesity among type 2 diabetes mellitus at Sidama Region, Southern Ethiopia. PLoS ONE. 2022;17(4):e0266716.
  • Tino S, Mayanja BN, Mubiru MC, et al. Prevalence and factors associated with overweight and obesity among patients with type 2 diabetes mellitus in Uganda-a descriptive retrospective study. BMJ Open. 2020;10(11):e039258.
  • Kiros KG, Abyu GY, Belay DS, et al. Magnitude of overweight and associated factors among type 2 diabetes mellitus patients at Mekelle public hospitals, Tigray, Ethiopia: a cross-sectional study. BMC Res Notes. 2019;12(1):762.
  • Damian DJ, Kimaro K, Mselle G, et al. Prevalence of overweight and obesity among type 2 diabetic patients attending diabetes clinics in Northern Tanzania. BMC Res Notes. 2017;10(1):515.
  • Adeniyi OV, Longo-Mbenza B, Ter Goon D. Female sex, poverty and globalization as determinants of obesity among rural South African type 2 diabetics: a cross-sectional study. BMC Public Health. 2015;15:298.
  • Balogun WO, Uloko AE, Ipadeola A, et al. Prevalence of obesity and ethno-geographic variation in body sizes of Nigerians with type 2 diabetes mellitus-a multi-centre study. Niger J Med. 2018;27(1):69–77.
  • Fasanmade OA, Okubadejo NU. Magnitude and gender distribution of obesity and abdominal adiposity in Nigerians with type 2 diabetes mellitus. Niger J Clin Pract. 2007;10(1):52–57.
  • Gezawa ID, Uloko AE, Gwaram BA, et al. Pattern of obesity among patients with type 2 diabetes at a tertiary healthcare center in Northern Nigeria. DMSO. 2019;12:2785–2790.
  • Kasimu S, Abdul Rahman MB. Prevalence of obesity among type 2 diabetic patients attending diabetes clinics in Sokoto northwestern Nigeria. SJPM. 2019;04(10):767–771.
  • Mogre V, Apala P, Nsoh JA, et al. Adiposity, hypertension and weight management behaviours in Ghanaian type 2 diabetes mellitus patients aged 20-70 years. Diabetes & Metabolic Syndrome. 2016;10(1):S79–S85.
  • Shiriyedeve S, Dlungwane TP, Tlou B. Factors associated with physical activity in type 2 diabetes mellitus patients at a public clinic in Gaborone, Botswana, in 2017. Afr J Prim Health Care Fam Med. 2019;11(1):e1–e7.
  • Sinamaw D, Getnet M, Abdulkadir M, et al. Patterns and associated factors of electrocardiographic abnormality among type 2 diabetic patients in Amhara National Regional State referral hospitals, Ethiopia: a multicenter institution-based cross-sectional study. BMC Cardiovasc Disord. 2022;22(1):230.
  • Bideberi AT, Mutagaywa R. Statin prescription patterns and associated factors among patients with type 2 diabetes mellitus attending diabetic clinic at Muhimbili National Hospital, Dar Es Salaam, Tanzania. DMSO. 2022;15:633–646.
  • Ebrahim H, Fiseha T, Ebrahim Y, et al. Comparison of hematological parameters between type 2 diabetes mellitus patients and healthy controls at Dessie Comprehensive Specialized Hospital, Northeast Ethiopia: comparative cross-sectional study. PLoS ONE. 2022;17(7):e0272145.
  • Seid MA, Ambelu A, Diress M, et al. Visual impairment and its predictors among people living with type 2 diabetes mellitus at Dessie town hospitals, Northeast Ethiopia: institution-based cross-sectional study. BMC Ophthalmol. 2022;22(1):52.
  • Abebe A, Wobie Y, Kebede B, et al. Self-care practice and glycemic control among type 2 diabetes patients on follow up in a developing country: a prospective observational study. J Diabetes Metab Disord. 2022;21(1):455–461.
  • Abera RG, Demesse ES, Boko WD. Evaluation of glycemic control and related factors among outpatients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a cross-sectional study. BMC Endocr Disord. 2022;22(1):54.
  • Umelo DO, Ugboma EW, Nwankwo NC, et al. Ultrasonographic evaluation of the achilles tendon in patients with type 2 diabetes: a dual center study in port Harcourt. Niger Health J. 2022;21(4):228–249.
  • Junaid OA, Ojo OA, Adejumo OA, et al. Malnutrition in elderly patients with type 2 diabetes mellitus in a Nigerian Tertiary Hospital: a cross-sectional study. Dialogues Health. 2022;1:100030.
  • Yusuf Adebayo R, Odeigha LO, Alabi AN, et al. Body mass index, blood pressure, and cognitive impairment among type 2 diabetic patients in a primary care setting, North-Central Nigeria. Ann Afr Med Res. 2022;5(1):158.
  • Sebai I, Oueslati I, Yazidi M, et al. Interest of the waist-to-height ratio to predict metabolic syndrome in type 2 diabetic patients. La Tunisie Medicale. 2022;100(2):137–142.
  • Kebede WM, Gizachew KD, Mulu GB. Prevalence and risk factors of dyslipidemia among type 2 diabetes patients at a referral hospital, North Eastern, Ethiopia. Ethiopian J Health Sci. 2021;31(6):1267–1276.
  • Shigidi MM, Karrar WN. Risk factors associated with the development of diabetic kidney disease in Sudanese patients with type 2 diabetes mellitus: a case-control study. Diabetes Metab Syndr. 2021;15(6):102320.
  • Ibrahim AO, Agboola SM, Elegbede OT, et al. Glycemic control and its association with sociodemographics, comorbid conditions, and medication adherence among patients with type 2 diabetes in Southwestern Nigeria. J Int Med Res. 2021;49(10):030006052110440.
  • Yosef T, Nureye D, Tekalign E. Poor glycemic control and its contributing factors among type 2 diabetes patients at Adama Hospital Medical College in East Ethiopia. Diabetes Metab Syndr Obes. 2021;14:3273–3280.
  • Omar SM, Musa IR, Idrees MB, et al. Prevalence of depression and associated factors among patients with type 2 diabetes mellitus in Eastern Sudan. BMC Psychiatry. 2021;21(1):336.
  • Regassa LD, Tola A. Magnitude and predictors of hospital admission, readmission, and length of stay among patients with type 2 diabetes at public hospitals of Eastern Ethiopia: a retrospective cohort study. BMC Endocr Disord. 2021;21(1):74.
  • Djonor SK, Ako-Nnubeng IT, Owusu EA, et al. Determinants of blood glucose control among people with type 2 diabetes in a regional hospital in Ghana. PLoS ONE. 2021;16(12):e0261455.
  • Kotiso KS, Degemu N, Gebremedhin S, et al. Determinants of hypertension among patients with type 2 diabetes mellitus on follow-up at Tikur Anbessa Specialized Hospital, Addis Ababa: a case-control study. PLoS ONE. 2021;16(8):e0256399.
  • Saasita PK, Senoga S, Muhongya K, et al. High prevalence of uncontrolled hypertension among patients with type 2 diabetes mellitus: a hospital-based cross-sectional study in southwestern Uganda. Pan Afr Med J. 2021;39:142.
  • Chetoui A, Kaoutar K, Elmoussaoui S, et al. Prevalence and determinants of poor glycaemic control: a cross-sectional study among Moroccan type 2 diabetes patients. International Health. 2022;14(4):390–397.
  • Otieno F, Ogola EN, Kimando MW, et al. The burden of unrecognised chronic kidney disease in patients with type 2 diabetes at a county hospital clinic in Kenya: implications to care and need for screening. BMC Nephrol. 2020;21(1):73.
  • Zerga AA, Bezabih AM. Metabolic syndrome and lifestyle factors among type 2 diabetes mellitus patients in Dessie Referral Hospital, Amhara Region, Ethiopia. PLoS ONE. 2020;15(11):e0241432.
  • Munyogwa MJ, William R, Kibusi SM, et al. Clinical characteristics and health care received among patients with type 2 diabetes attending secondary and tertiary healthcare facilities in Mwanza Region, Tanzania: a cross-sectional study. BMC Health Serv Res. 2020;20(1):527.
  • Taderegew MM. Assessment of renal impairment using estimated glomerular filtration rate among type 2 diabetes mellitus patients in North-East Ethiopia: a cross-sectional study. J Diabetes Metab Disord. 2020;19(2):1473–1481.
  • Haile K, Timerga A. Dyslipidemia and its associated risk factors among adult type-2 diabetic patients at Jimma University Medical Center, Jimma, Southwest Ethiopia. Diabetes Metab Syndr Obes. 2020;13:4589–4597.
  • Akalu Y, Birhan A. Peripheral arterial disease and its associated factors among type 2 diabetes mellitus patients at Debre Tabor general hospital, northwest Ethiopia. J Diabetes Res. 2020;2020:9419413.
  • Kouitcheu Mabeku LB, Noundjeu Ngamga ML, Leundji H. Helicobacter pylori infection, a risk factor for type 2 diabetes mellitus: a hospital-based cross-sectional study among dyspeptic patients in Douala-Cameroon. Sci Rep. 2020;10(1):12141.
  • Achila OO, Ghebretinsae M, Kidane A, et al. Factors associated with poor glycemic and lipid levels in ambulatory diabetes mellitus type 2 patients in Asmara, Eritrea: a cross-sectional study. J Diabetes Res. 2020;2020:5901569.
  • Abdissa D, Hamba N, Kene K, et al. Prevalence and determinants of peripheral neuropathy among type 2 adult diabetes patients attending Jimma University Medical Center, Southwest Ethiopia, 2019, an institutional-based cross-sectional study. Journal of Diabetes Research. 2020;2020:9562920.
  • Abdallah MA, Mohammed Esmayel E, Mayada Mohamed Moussa MMM. Assessment of health related life quality in type 2 diabetic patients in Zagazig University Hospitals. Zagazig University Medical Journal. 2019;25(6):790–800.
  • Bello-Ovosi BO, Ovosi JO, Ogunsina MA, et al. Prevalence and pattern of dyslipidemia in patients with type 2 diabetes mellitus in Zaria, Northwestern Nigeria. Pan Afr Med J. 2019;34:123.
  • Karau PB, Kirna B, Amayo E, et al. The prevalence of vitamin D deficiency among patients with type 2 diabetes seen at a referral hospital in Kenya. Pan Afr Med J. 2019;34:38.
  • Anioke IC, Ezedigboh AN, Dozie-Nwakile OC, et al. Predictors of poor glycemic control in adult with type 2 diabetes in South-Eastern Nigeria. Afr H Sci. 1970;19(4):2819–2828.
  • Asamoah-Boaheng M, Tenkorang EY, Sarfo-Kantanka O. Time to onset of type 2 diabetes mellitus in Ghana. International Health. 2019;11(2):101–107.
  • Ekoru K, Doumatey A, Bentley AR, et al. Type 2 diabetes complications and comorbidity in Sub-Saharan Africans. EClinicalMedicine. 2019;16:30–41.
  • Bekele A, Teji Roba K, Egata G, et al. Anemia and associated factors among type-2 diabetes mellitus patients attending public hospitals in Harari Region, Eastern Ethiopia. PLoS ONE. 2019;14(12):e0225725.
  • Fekadu G, Bula K, Bayisa G, et al. Challenges and factors associated with poor glycemic control among type 2 diabetes mellitus patients at Nekemte Referral Hospital, Western Ethiopia. J Multidiscip Healthc. 2019;12:963–974.
  • Bouhajja H, Kacem FH, Abdelhedi R, et al. Potential predictive role of lipid peroxidation markers for type 2 diabetes in the adult Tunisian population. Can J Diabetes. 2018;42(3):263–271.
  • Sarfo-Kantanka O, Sarfo FS, Ansah EO, et al. The effect of thyroid dysfunction on the cardiovascular risk of type 2 diabetes mellitus patients in Ghana. J Diabetes Res. 2018;2018:4783093.
  • Wolde HF, Atsedeweyen A, Jember A, et al. Predictors of vascular complications among type 2 diabetes mellitus patients at university of Gondar Referral Hospital: a retrospective follow-up study. BMC Endocr Disord. 2018;18(1):52.
  • Birkinshaw A, Nel R, Walsh C. Adherence of patients with type 2 diabetes mellitus with the SEMDSA lifestyle guidelines. J Endocrinol Metab Diabetes South Afr. 2018;23(2):39–45.
  • Gudjinu HY, Sarfo B. Risk factors for type 2 diabetes mellitus among out-patients in Ho, the Volta regional capital of Ghana: a case-control study. BMC Res Notes. 2017;10(1):324.
  • Otieno CF, Kanu JE, Karari EM, et al. Glucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in Kenya. DMSO. 2017;10:141–149.
  • Ojieabu WA, Odusan O, Ojieabu NI, et al. Evaluation of prevalence of micro- and macrovascular complications among elderly type 2 diabetes patients in a health facility. Afr. J. Biomed. Res. 2017;20:131–135.
  • Mwanri AW, Lyari G, Msollo SS. Nutritional status and the use of traditional medicine among diabetic patients in Mawenzi Hospital, Tanzania. Tanzania J Agric Sci. 2017;16(1):36–45.
  • Goie TT, Naidoo M. Awareness of diabetic foot disease amongst patients with type 2 diabetes mellitus attending the chronic outpatients department at a regional hospital in Durban, South Africa. Afr J Prim Health Care Fam Med. 2016;8(1):e1. e8.
  • Habtewold TD, Alemu SM, Haile YG. Sociodemographic, clinical, and psychosocial factors associated with depression among type 2 diabetic outpatients in black lion general specialized hospital, Addis Ababa, Ethiopia: a cross-sectional study. BMC Psychiatry. 2016;16(1):103.
  • Belkacemi L, Belalia M. Cross-sectional pilot study about the liver enzymes profile in type 2 diabetic patients from an Algerian West Region: Wilaya of Mostaganem. Diabetes Metab Syndr. 2016;10(1 Suppl 1):S147–S150.
  • Adebola SO, Olamoyegun MA, Sogebi OA, et al. Otologic and audiologic characteristics of type 2 diabetics in a tertiary health institution in Nigeria. Braz J Otorhinolaryngol. 2016;82(5):567–573.
  • Diaf M, Khaled BM, Sellam F. Impact of corpulence parameters and haemoglobin A1c on metabolic control in type 2 diabetic patients: comparison of apolipoprotein B/A-I ratio with fasting and postprandial conventional lipid ratios. Libyan J Med. 2015;10(1):27400.
  • Camara A, Baldé NM, Sobngwi-Tambekou J, et al. Poor glycemic control in type 2 diabetes in the South of the Sahara: the issue of limited access to an HbA1c test. Diabetes Res Clin Pract. 2015;108(1):187–192.
  • Ndege BW, Diero LO, Owiti MO, et al. Prevalence, treatment and control of hypertension among type 2 diabetic patients at Moi Teaching and Referral Hospital, Eldoret, Kenya. East Afr Med J. 2014;91(8):253–260.
  • Kamuhabwa AR, Charles E. Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar Es Salaam. Drug Healthcare Patient Saf. 2014;6:155–165.
  • Mogre V, Abedandi R, Salifu ZS. Distorted self-perceived weight status and underestimation of weight status in diabetes mellitus type 2 patients. PLoS One. 2014;9(4):e95165.
  • Brenyah RC, Ephraim RKD, Owiredu W, et al. Prevalence and determinants of proteinuria among type 2 diabetics in Kumasi, Ghana. J Med Biomed Sci. 2013;2(1):13–21.
  • Okafor CI, Ofoegbu EN. Control to goal of cardiometabolic risk factors among Nigerians living with type 2 diabetes mellitus. Niger J Clin Pract. 2012;15(1):15–18.
  • Berraho M, El Achhab Y, Benslimane A, et al. Hypertension and type 2 diabetes: a cross-sectional study in Morocco (EPIDIAM study). Pan Afr Med J. 2012;11:52.
  • Danquah I, Bedu-Addo G, Terpe KJ, et al. Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors. BMC Public Health. 2012;12:210.
  • Acquah S, Boampong JN, Adusu J, et al. Lipid and lipoprotein levels in type 2 diabetes patients attending the Central Regional Hospital in the Cape Coast Metropolis of Ghana. Int J Health Res. 2011;4(2):75–82.
  • Baba MM, Kolawole BA, Ikem RT, et al. Serum C-reactive protein in Nigerians with type II diabetes mellitus. Niger Q J Hosp Med. 2010;20(3):108–113.
  • Elnasri HA, Ahmed AM. Patterns of lipid changes among type 2 diabetes patients in Sudan. Eastern Mediterr Health J. 2008;14(2):314–324.
  • Alshkri M, Elmehdawi R. Metabolic syndrome among type-2 diabetic patients in Benghazi-Libya: a pilot study. Libyan J Med. 2008;3(4):177–180.
  • Ajayi EA, Ajayi AO, Olalekan OE. Treatment to targets in type 2 diabetics: analysis of out-patients practice at a remote Western Nigerian hospital. Internet J Med Update. 2010;5(2):8–14.
  • Choukem SP, Kengne AP, Dehayem YM, et al. Hypertension in people with diabetes in Sub-Saharan Africa: revealing the hidden face of the iceberg. Diabetes Res Clin Pract. 2007;77(2):293–299.
  • Akande AA, Jimoh AK, Akinyinka OA, et al. Serum uric acid level as an independent component of the metabolic syndrome in type 2 diabetic blacks. Niger J Clin Pract. 2007;10(2):137–142.
  • Adediran OS, Jimoh AK, Edo AE, et al. Correlation of various anthropometric indices among Nigerians with type 2 diabetes mellitus. Highland Med Res J. 2007;5(1):33–48.
  • Makuyana D, Gomo Z, Munyombwe T, et al. Metabolic syndrome disorders in urban black Zimbabweans with type 2 diabetes mellitus. Central Afr J Med. 2004;50(3–4):24–29.
  • Tuei VC, Maiyoh GK, Ha CE. Type 2 diabetes mellitus and obesity in subSaharan Africa. Diabetes Metab Res Rev. 2010;26(6):433–445.
  • Smati S, Tramunt B, Wargny M, et al. Relationship between obesity and severe COVID-19 outcomes in patients with type 2 diabetes: results from the CORONADO study. Diabetes Obes Metab. 2021;23(2):391–403.
  • Daousi C, Casson IF, Gill GV, et al. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Postgrad Med J. 2006;82(966):280–284.
  • Andary R, Fan W, Wong ND. Control of cardiovascular risk factors among US adults with type 2 diabetes with and without cardiovascular disease. Am J Cardiol. 2019;124(4):522–527.
  • OECD/SWAC. 2020. Africa’s urbanisation dynamics 2020: Africapolis, mapping a new urban geography, West African studies. Paris: OECD Publishing.
  • Ecker O, Nene M. 2012. Nutrition policies in developing countries: challenges and highlights. IFPRI Policy Note.
  • Cooper AJ, Gupta SR, Moustafa AF, et al. Sex/gender differences in obesity prevalence, comorbidities, and treatment. Curr Obes Rep. 2021;10(4):458–466.
  • Kanter R, Caballero B. Global gender disparities in obesity: a review. Adv Nutr. 2012;3(4):491–498.
  • Ben-Yacov L, Ainembabazi P, Stark AH, et al. Prevalence and sex-specific patterns of metabolic syndrome in rural Uganda. BMJNPH. 2020;3(1):11–17.
  • Adeboye B, Bermano G, Rolland C. Obesity and its health impact in Africa: a systematic review. CVJA. 2012;23(9):512–521.
  • Rochlani Y, Pothineni NV, Kovelamudi S, et al. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017;11(8):215–225.
  • Leggio M, Lombardi M, Caldarone E, et al. The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins. Hypertens Res. 2017;40(12):947–963.
  • Oh TJ, Lee JE, Choi SH, et al. Association between body fat and diabetic peripheral neuropathy in middle-aged adults with type 2 diabetes mellitus: a preliminary report. JOMES. 2019;28(2):112–117.